contezolid acefosamil

DRUG2 trials

Sponsors

Micurx Pharmaceuticals Inc., MicuRx

Conditions

Diabetic Foot InfectionsGram-Positive Bacterial InfectionsSkin Diseases, Bacterial

Phase 2

Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection

CompletedNCT03747497

MicuRxGram-Positive Bacterial Infections, Skin Diseases, Bacterial

Start: 2018-11-15End: 2019-03-26Updated: 2022-11-08

Phase 3

A Phase 3, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults with Moderate or Severe Diabetic Foot Infections

RecruitingCTIS2022-500257-16-00

Micurx Pharmaceuticals Inc.Diabetic Foot Infections

Start: 2023-03-17Target: 791Updated: 2025-07-15